BIONPHARMA INC. announced the U.S. approval of generic metformin hydrochloride oral solution (ANDA 219151), a move that is expected to bolster supply chain stability for the widely prescribed diabetes management medication. This approval will ultimately expand market competition, potentially exerting downward pressure on pricing for the essential oral drug.